Contact Pancreatitis Supporter`s Network
Contact The PSN Team
Please give us as much information as possible about your enquiry all emails are read although
unfortunately it is not always possible to reply to everyone. We thank you for your comments and feedback because the Pancreatitis Supporters’ Network relies on the support and input from its members and guests.
Keep Smiling Everybody The PSN Team.
Latest News
Boston Scientific Endoscopy Presents Promising Clinical Data During Digestive ...
Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide ...
AXIOS(TM) Stent and Delivery System Study Demonstrates Successful Treatment of ...
Chamomile has a life-saving secret
Dear Pharmacist: Chamomile offers a life-saving secret
Novartis drug pasireotide LAR shows superior efficacy compared to SandostatinR ...
Body at Cox was of former patient
Isis Pharmaceuticals' CEO Discusses Clinical Development Plans for ...
Blitz on foreign patients halves $30m health bill
Anti-NGF painkillers back on track?
Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with ...
REPLIGEN CORPORATION : Repligen Reports First Quarter 2012 ...
6 Biotech Stocks With Huge Potential In June
Warning about Diabetes Treatment Victoza
The Benefit of Low Fat Pet Food in Dogs with GI Disease
Repligen Says FDA May Seek More Data on Imaging Drug
Jazz Pharmaceuticals Enters Definitive Agreement to Acquire EUSA Pharma
Amsterdam Molecular Therapeutics Reports Full Year Results 2011
Repligen says FDA may seek more data on pancreatic imaging drug
Program draws attention to the dangers of strokes
Boston Scientific Endoscopy Presents Promising Clinical Data During Digestive ...
Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide ...
AXIOS(TM) Stent and Delivery System Study Demonstrates Successful Treatment of ...
Chamomile has a life-saving secret
Dear Pharmacist: Chamomile offers a life-saving secret
Novartis drug pasireotide LAR shows superior efficacy compared to SandostatinR ...
Body at Cox was of former patient
Isis Pharmaceuticals' CEO Discusses Clinical Development Plans for ...
Blitz on foreign patients halves $30m health bill
Anti-NGF painkillers back on track?
Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with ...
REPLIGEN CORPORATION : Repligen Reports First Quarter 2012 ...
6 Biotech Stocks With Huge Potential In June
Warning about Diabetes Treatment Victoza
The Benefit of Low Fat Pet Food in Dogs with GI Disease
Repligen Says FDA May Seek More Data on Imaging Drug
Jazz Pharmaceuticals Enters Definitive Agreement to Acquire EUSA Pharma
Amsterdam Molecular Therapeutics Reports Full Year Results 2011
Repligen says FDA may seek more data on pancreatic imaging drug
Program draws attention to the dangers of strokes








